Press releases of year 2008
18/11/2008
Novagali Pharma announces that it has notified the European Medicines Agency (EMEA) of its decision to withdraw its application for a marketing authorization for the medicine Vekacia® intended to treat vernal keratoconjunctivitis (VKC), an ophthalmic orphan disease affecting mostly children.
26/09/2008
Novagali Pharma announces today it has secured €15 million in a new financing round with the participation of the historical Company investors.
24/04/2008
Novagali Pharma successfully enrolls first patient in U.S. Phase I Clinical Study with CORTIJECT® for Diabetic Macular Edema
09/04/2008
Novagali Pharma announces the launch of Cationorm®.
18/01/2008
Novagali Pharma Announces FDA Clearance of IND for US Clinical Trial of Nova63035 in patients with Diabetic Macular Edema.